During cancer progression, hyaluronan synthase 2 (HAS2) and the cell migration inducing hyaluronidase 2 (CEMIP2, also known as TMEM2), are upregulated, promoting tumorigenesis [7,8]. This evidence concerns the gene CEMIP2 and cancer.